SCHEMBL21135767

SCHEMBL21135767

CCC(F)(OC(=O)C1CCCCC1)S(=O)(=O)O

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.37
SMN1; SMN2 Q16637 2/20 0.33
TSHR P16473 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
NAAA Q02083 1/20 0.33
ENPP3 O14638 2/20 0.33
ENPP1 P22413 2/20 0.33
ENPP2 Q13822 2/20 0.33
ADRB2 P07550 1/20 0.33
ADRB1 P08588 1/20 0.33
ADRB3 P13945 1/20 0.33
CES2 O00748 1/20 0.31
CES1 P23141 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
HSD11B1 P28845 1/20 0.31
GAA P10253 1/20 0.31
RECQL P46063 1/20 0.31
HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21136602 0.88 ALDH1A1 (0.35) ALDH1A1SMN1; SMN2TSHRL3MBTL1NAAA
SCHEMBL21136611 0.85 ALDH1A1 (0.33) ALDH1A1SMN1; SMN2ADRB2ADRB1ADRB3
SCHEMBL21136608 0.83 ALDH1A1 (0.34) ALDH1A1SMN1; SMN2CES2CES1KMT2A
SCHEMBL21136378 0.82 SMN1; SMN2 (0.33) ALDH1A1SMN1; SMN2ENPP3ENPP1ENPP2
SCHEMBL21136607 0.82 EPHX2 (0.36) ALDH1A1SMN1; SMN2TSHRL3MBTL1NAAA
SCHEMBL21136603 0.78 CES2 (0.33) SMN1; SMN2CES2CES1KMT2A
SCHEMBL21136609 0.76 EPHX1 (0.33) ALDH1A1MEN1KMT2A
SCHEMBL21136606 0.76 SMN1; SMN2 (0.34) ALDH1A1SMN1; SMN2TSHRADRB2ADRB1
SCHEMBL25889183 0.76 CES2 (0.34) ALDH1A1SMN1; SMN2ENPP3ENPP1ENPP2
SCHEMBL1130166 0.73 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2NAAAADRB2ADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190196326-A1 ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM, PATTERN FORMING METHOD, AND METHOD OF MANUFACTURING ELECTRONIC DEVICE FUJIFILM CORPORATION (JP) 2019-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190196326-A1 ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM, PATTERN FORMING METHOD, AND METHOD OF MANUFACTURING ELECTRONIC DEVICE RER1, ACTR5, RAD51 ALDH1A1 1556/4885SMN1; SMN2 3245/4885TSHR 1775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.